Deloitte Access Economics Report: Cost effectiveness of pain devices

The Neuromodulation Society of Australia and New Zealand (NSANZ), engaged Deloitte Access Economics to estimate the cost effectiveness of neuromodulation treatment through spinal cord stimulation (SCS) and intrathecal pumps, which are collectively referred to as pain devices.

View full report PDF

Private Health Insurance Policies

Potential differences in Private Health Insurance policy coverage for Pain Management with/without device and other selected categories

View document PDF

© 2024 NSANZ     |    Privacy Policy    |    Contact Us
scroll to top

Search site